Literature DB >> 16798390

Kuru in the 21st century--an acquired human prion disease with very long incubation periods.

John Collinge1, Jerome Whitfield, Edward McKintosh, John Beck, Simon Mead, Dafydd J Thomas, Michael P Alpers.   

Abstract

BACKGROUND: Kuru provides the principal experience of epidemic human prion disease. Its incidence has steadily fallen after the abrupt cessation of its route of transmission (endocannibalism) in Papua New Guinea in the 1950s. The onset of variant Creutzfeldt-Jakob disease (vCJD), and the unknown prevalence of infection after the extensive dietary exposure to bovine spongiform encephalopathy (BSE) prions in the UK, has led to renewed interest in kuru. We investigated possible incubation periods, pathogenesis, and genetic susceptibility factors in kuru patients in Papua New Guinea.
METHODS: We strengthened active kuru surveillance in 1996 with an expanded field team to investigate all suspected patients. Detailed histories of residence and exposure to mortuary feasts were obtained together with serial neurological examination, if possible.
FINDINGS: We identified 11 patients with kuru from July, 1996, to June, 2004, all living in the South Fore. All patients were born before the cessation of cannibalism in the late 1950s. The minimum estimated incubation periods ranged from 34 to 41 years. However, likely incubation periods in men ranged from 39 to 56 years and could have been up to 7 years longer. PRNP analysis showed that most patients with kuru were heterozygous at polymorphic codon 129, a genotype associated with extended incubation periods and resistance to prion disease.
INTERPRETATION: Incubation periods of infection with human prions can exceed 50 years. In human infection with BSE prions, species-barrier effects, which are characteristic of cross-species transmission, would be expected to further increase the mean and range of incubation periods, compared with recycling of prions within species. These data should inform attempts to model variant CJD epidemiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798390     DOI: 10.1016/S0140-6736(06)68930-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  97 in total

1.  Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models.

Authors:  Caroline Lacroux; Didier Vilette; Natalia Fernández-Borges; Claire Litaise; Séverine Lugan; Nathalie Morel; Fabien Corbière; Stéphanie Simon; Hugh Simmons; Pierrette Costes; Jean-Louis Weisbecker; Isabelle Lantier; Frederic Lantier; François Schelcher; Jacques Grassi; Joaquin Castilla; Olivier Andréoletti
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

3.  Disease transmission by cannibalism: rare event or common occurrence?

Authors:  Volker H W Rudolf; Janis Antonovics
Journal:  Proc Biol Sci       Date:  2007-05-07       Impact factor: 5.349

4.  Good and bad news about transmissible spongiform encephalopathies (prion diseases).

Authors:  Richard T Johnson
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

5.  Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.

Authors:  Julie Ann Edgeworth; Graham S Jackson; Anthony R Clarke; Charles Weissmann; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

6.  Epidemiological mechanisms of genetic resistance to kuru.

Authors:  Katherine E Atkins; Jeffrey P Townsend; Jan Medlock; Alison P Galvani
Journal:  J R Soc Interface       Date:  2013-06-05       Impact factor: 4.118

Review 7.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

Review 8.  Prion-Like Protein Aggregates and Type 2 Diabetes.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

9.  Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.

Authors:  Rodrigo Morales; Lisbell D Estrada; Rodrigo Diaz-Espinoza; Diego Morales-Scheihing; Maria C Jara; Joaquin Castilla; Claudio Soto
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

10.  Bacterial colitis increases susceptibility to oral prion disease.

Authors:  Christina J Sigurdson; Mathias Heikenwalder; Giuseppe Manco; Manja Barthel; Petra Schwarz; Bärbel Stecher; Nike J Krautler; Wolf-Dietrich Hardt; Burkhardt Seifert; Andrew J S MacPherson; Irène Corthesy; Adriano Aguzzi
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.